In the United States, ozanimod is indicated for the treatment of adults with relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and …

Nov 12, 2024 · Ozanimod is used to treat relapsing forms of multiple sclerosis. Learn about side effects, interactions and indications.

Ozanimod is in a class of medications called sphingosine l-phosphate receptor modulators. It works by decreasing the action of immune cells that may cause nerve damage.

Dec 1, 2025 · Ozanimod is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive …

ZEPOSIA ® (ozanimod) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active …

Ozanimod is a sphingosine 1-phosphate (S1P) receptor modulator that binds with high afinity to S1P receptors 1 and 5. Ozanimod blocks the capacity of lymphocytes to egress from lymph …

Ozanimod Capsules What is this medication? OZANIMOD (oh ZAN i mod) treats multiple sclerosis (MS). It works by slowing down an overactive immune system, which prevents or …

View ozanimod information, including dose, uses, side-effects, pregnancy, breast feeding, contra-indications, monitoring requirements and drug action.

Ozanimod hydrochloride, a selective sphingosine 1-phosphate (S1P) receptor modulator, has immunomodulatory and disease-modifying activity in multiple sclerosis (MS).

Ozanimod is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing …